TriGuard Cerebral Protection Device Demonstrates Safety and Significant Improvements in... - 0 views
-
keystoneheart on 15 Oct 18CAESAREA, Israel & TAMPA, Fla.-September 19, 2016 - Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac procedures, today announces the safety and efficacy of the TriGuardâ„¢ Cerebral Embolic Protection device when used during Transcatheter Aortic Valve Replacement (TAVR), according to preliminary findings from real-world experience of 51 patients discussed at the PCR London Valves 2016 Conference today in London, England.